ATH 25.0% 0.5¢ alterity therapeutics limited

Lundback should now launch their failed 5-HT6 drug directly into...

  1. 6,213 Posts.
    lightbulb Created with Sketch. 365
    Lundback should now launch their failed 5-HT6 drug directly into canine trials.......don't know why they should mind you.....there is absolutely no link or relevance given it was well tolerated in humans.....but it stands to reason that (given FDA logic of AD drugs) that some type of analysis/comparison should follow. I'm just wondering if this drug will be also placed in a PCH until it is 'canine compared !!!' Bloody hell,the more you parody our predicament the more absurd it appears !!!!!!!
 
watchlist Created with Sketch. Add ATH (ASX) to my watchlist
(20min delay)
Last
0.5¢
Change
0.001(25.0%)
Mkt cap ! $26.19M
Open High Low Value Volume
0.5¢ 0.5¢ 0.5¢ $27.94K 6.050M

Buyers (Bids)

No. Vol. Price($)
46 57663299 0.4¢
 

Sellers (Offers)

Price($) Vol. No.
0.5¢ 56205001 43
View Market Depth
Last trade - 16.10pm 29/03/2024 (20 minute delay) ?
Last
0.5¢
  Change
0.001 ( 0.00 %)
Open High Low Volume
0.5¢ 0.5¢ 0.5¢ 20524121
Last updated 15.46pm 29/03/2024 ?
ATH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.